0.50Open0.50Pre Close0 Volume5 Open Interest20.00Strike Price0.00Turnover105.46%IV25.69%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.50Extrinsic Value100Contract SizeAmericanOptions Type-0.1252Delta0.0290Gamma52.48Leverage Ratio-0.0299Theta-0.0023Rho-6.57Eff Leverage0.0139Vega
EverQuote Stock Discussion
• $Belite Bio(BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore(ATKR.US)$ +12.11% (earnings reports)
• $AST SpaceMobile(ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic(HLIT.US)$ +7.56% (earnings reports)
• $The Chemours(CC.US)$ +7.2% ...
• $Agora(API.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE(ARGX.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp(IDA.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific(JAKK.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA(KOF.US)$ : Barclays Upgrades to Overweight from Equal Wei...
$EverQuote(EVER.US)$ JP Morgan reduced EverQuote, Inc. EVER price target from $41 to $17
$Triterras(TRIT.US)$ B. Riley Securities cut the price target on Triterras, Inc. TRIT from $9 to $5
No comment yet